Abstract
Background Children (<18 years old) were not initially considered significant sources of infection (SOIs) for SARS-CoV-2. Risk mitigation strategies were thus prioritized for adults, and vaccination was inaccessible for children until mid-2021. Emergence of novel variants led to significant increases in COVID-19 cases in both children and adults. Whether these emergence events and increased vulnerability of unvaccinated children had a synergistic effect resulting in increased caseloads in adults requires further exploration.
Methods A retrospective cohort study was conducted among 3,545 workers diagnosed with COVID-19. Case details were compiled during contact investigations. Variants of concern were identified following sequencing of biological samples collected through employer-based testing programs. Logistic regression was performed to compare the odds of having a child SOI based on the dominant variant in the workforce.
Results One-fourth (24.5%) of the cohort reported having a child in-residence; 11.2% identified a child as their SOI. In Alpha-dominant months, the odds of having a child SOI were 0.3, and the child SOI was likely older (5-17 years old). The odds of having a child SOI increased to 1.3 and 2.2 in Delta- and Omicron-dominant months, respectively. The odds of having younger child SOIs (<5 years old) were significantly higher in Omicron-dominant months.
Conclusions Children were highly likely to acquire the virus and posed a significant risk of transmission to their adult caretakers during Delta- and Omicron-dominant months. Without proper mitigation strategies in both the home and the workplace, child-associated transmission can threaten operations in the forms of staff shortages.
What is already known on this topic Increases in transmission trends related to SARs-CoV-2 Variants of Concern have been documented in the literature at the population level and in workplaces.
What this study adds This study looks more closely at the role that children played in transmission to adult workers, and therefore their potential to seed transmission outside of the home. This interface of transmission has been neglected in the literature but is key for future policy development.
How this study might affect research, practice, or policy Transmission of SARS-CoV-2 from children to their caretakers may cause significantly increased odds of infection in a worker population. This may have second order effects for staffing, particularly in workgroups with employees of childbearing age. Employers should consider this in the design of their policies for continuity of operations, telework, and leave.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by the Division of Intramural Research (DIR) of the NIAID/NIH
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Analysis was conducted using deidentified data that were collected for public health purposes and determined as exempted from IRB as assessed by both National Institutes of Health IRB and George Washington University IRB.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- Adj
- adjusted
- AZ
- Arizona, USA
- BMI
- body mass index, = kilograms/meters2
- CC
- NIH clinical center
- CDC
- Centers for Disease Control and Prevention
- CI
- confidence interval
- CIR
- child(ren) in-residence
- COVID-19
- Coronavirus disease 2019
- Ct
- cycle threshold, for PCR testing
- DLM
- Department of Laboratory Medicine
- DIR
- Division of Intramural Research
- FDA
- Food and Drug Administration Group 0 – essential workers
- Group A/B
- non-essential, priority workers
- Group C
- teleworkers
- IC
- index case (NIH worker who reported a positive result)
- MD
- Maryland, USA
- MT
- Montana, USA
- mRNA
- messenger ribonucleic acid
- NC
- North Carolina, USA
- NIAID
- National Institutes of Allergy and Infectious Disease
- NIH
- National Institutes of Health
- NIEHS
- National Institute of Environmental Health Sciences, campus located in NC
- NIDDK
- National Institute of Diabetes and Digestive and Kidney Diseases, located in AZ Ns – not significant, p-value >0.05
- OMS
- Office of Medical Safety
- OR
- odds ratio
- PCR
- polymerase chain reaction
- POI
- period of infectivity
- Ref
- reference group, for regression analyses
- RML
- Rocky Mountain Labs, campus located in MT
- RWTG
- return-to-work group, either Group 0, Group A, Group B, or Group C
- SARS-CoV- 2
- severe acute respiratory syndrome coronavirus 2
- Sig.
- significance, p-values <0.5*, <0.01**, <0.001***, <0.0001****
- SOI
- source of infection
- TGrp
- time group
- UTD
- up to date, defined as >14 days post-primary series OR >7 days post-booster dose
- VOC
- variant of concern
